INTRODUCTION
============

Ethylene glycol monomethyl ether (EGME) is a glycol ether compound found in a variety of industrial products, including paints, inks, hydraulic fluids, and jet fuels (Johanson, [@b13]). Exposure to EGME causes various male and female reproductive defects as well as developmental abnormalities (Miller et al., [@b19]; Foster et al., [@b7]; Terry et al., [@b33]; Weng et al., [@b37]). Gestation day 8 mice treated with EGME exhibited neural tube malformations, including exencephaly and spina bifida occulta (Terry et al., [@b33]). EGME is oxidized by alcohol dehydrogenase to form methoxyaldehyde (MALD); MALD is rapidly oxidized by aldehyde dehydrogenase to form the stable metabolite 2-methoxyacetic acid (2-MAA; Welsch, [@b35]). The oxidative metabolism of EGME to 2-MAA is a prerequisite for embryotoxicity (Sleet et al., [@b30]). In utero 2-MAA exposure increases the incidence of hydrocephalus, hydronephrosis, heart, tail and limb malformations in species ranging from rodents to nonhuman primates (Brown et al., [@b4]; Scott et al., [@b28]). 2-MAA is also a developmental toxicant in vitro (Foster et al., [@b8]). Indeed, 2-MAA was selected as a class II test chemical for the European Centre for the Validation of Alternative Methods (ECVAM) international validation study on in vitro embryotoxicity tests (Brown, [@b3]).

Although 2-MAA is a well-established teratogen, its molecular mechanism of action is unclear. Disturbances in folate-dependent one-carbon transfer reactions (Welsch et al., [@b36]), chondrogenesis (Scofield et al., [@b27]), and apoptosis (Bagchi et al., [@b1]) have all been implicated in the teratogenicity induced by 2-MAA. An additional possibility is that the teratogenicity of 2-MAA is mediated by disturbances in acetylation programming. In vivo and in vitro studies have shown that 2-MAA inhibits histone deacetylase (HDAC) activity (Jansen et al., [@b11]). The significant hyperacetylation of core histones in testicular germ cells after 2-MAA exposure was attributed to both an increase in histone acetyltransferase (HAT) activity and a decrease in HDAC activity (Wade et al., [@b34]); furthermore, it was suggested that the 2-MAA-induced increase in histone acetylation played a role in spermatocyte death.

The acetylation of core histones by HATs and their deacetylation by HDACs are necessary to balance the opening and closing of chromatin structure that is responsible for the expression of various genes, many of which are important in embryonic development (Lehrmann et al., [@b16]). Both HATs and HDACs play an important role during development, as observed from different gene knockout studies. For example, mice lacking both p300 alleles are embryonic lethal at midgestation (Yao et al., [@b39]). The deletion of class 1 HDACs in transgenic mice is embryolethal at early stages of development (Lagger et al., [@b14]). Deletion of HDAC class 2 produced mice with phenotypic changes in cartilage development (Zhang et al., [@b40]). There is also growing evidence that HDAC inhibition is an important mechanism for teratogenesis. A study by Menegola et al. ([@b18]) demonstrated that trichostatin A and valproic acid, known HDAC inhibitors, caused axial malformations in CD-1 mice after treatment on gestation day 8. Furthermore, Paradis and Hales ([@b23]) showed that exposure to valproic acid caused significant limb abnormalities in vitro.

HAT and HDAC enzymes have both histone and nonhistone protein substrates (Gregoretti et al., [@b9]). The tumor suppressor transcription factor p53 is an example of a nonhistone protein target (Jin et al., [@b12]). Although p53 knockout mice are viable, they exhibit a gender-dependent increase in the incidence of developmental abnormalities such as neural tube defects (Sah et al., [@b26]). Either the overexpression or underexpression of wild-type p53 may have adverse effects on development (Choi and Donehower, [@b5]). Furthermore, p53 may have a role in protecting the embryo against teratogens. Moallem and Hales ([@b20]) demonstrated that limb buds from homozygous *p53*-knockout mice were more affected by exposure to a preactivated form of the anticancer drug cyclophosphamide (4-hydroperoxycyclophosphamide), then were limbs from p53 wild-type mice.

The stability and function of p53 are regulated in part by acetylation (Luo et al., [@b17]). Acetylated p53 not only enables the recruitment of important transcriptional complexes to the promoter region, but also allows for the transcription of p53 target genes (Singh et al., [@b29]). Such p53 target genes include cyclin-dependent kinase inhibitor 1A (*Cdnk1a* or *p21*) and BLC2-associated X protein (*Bax*), genes that are important for the regulation of cell cycle arrest and apoptosis, respectively (Roy et al., [@b25]). However, the cellular response to undergo cell cycle arrest or apoptosis depends on the "acetylation signature" of p53 (Sykes et al., [@b31]; Tang et al., [@b32]). For example, acetylation of p53 at K320 leads to apoptosis, while ubiquitylation at this same site leads to cell cycle arrest (Le Cam et al., [@b15]).

We hypothesize that the adverse effects of EGME on limb development are mediated by 2-MAA-induced dysregulation of the acetylation of histone and nonhistone proteins, resulting in changes in cell cycle arrest and programmed cell death. To test this hypothesis, we determined the effects of in vitro exposure to increasing concentrations of EGME and 2-MAA on developing mouse limb buds and on the acetylation of histones H3K9 and H4K12 and of a nonhistone protein, p53K379. Furthermore, we elucidated the effects of EGME and 2-MAA on downstream markers of cell cycle arrest (*p21*) and apoptosis (cleaved caspase-3).

MATERIALS AND METHODS
=====================

Limb Bud Cultures and Drug Treatments
-------------------------------------

All animal studies complied with the guidelines established by the Canadian Council on Animal Care under protocol 1825. Timed-pregnant CD1 mice (20--25 g; Charles River Canada, St-Constant, QC, Canada) were mated between 0900 and 1100 h. The mating day was considered to be gestation day 0. On gestation day 12, between 0900 and 1100 h, females were euthanized by CO~2~ inhalation and cervical dislocation and their embryos were explanted in sterile Hank\'s balanced salt solution (Sigma Aldrich Canada, Oakville, ON). The embryonic forelimbs were cultured, as previously described (Huang and Hales, [@b10]). Briefly, embryonic forelimbs were excised immediately lateral to the somites, pooled and cultured in roller bottles containing 6 ml culture medium, consisting of 75% BGJb Medium (GIBCO BRL Products, Burlington, ON, Canada), 25% salt solution, ascorbic acid (160 μg/ml), and gentamycin (1 μl/ml, GIBCO BRL Products). Each culture was gassed with a mixture of 50% O~2~, 5% CO~2~, and 45% N~2~ for 2 min. Different concentrations (3, 10, or 30 mM) of EGME (99% pure, Sigma Aldrich) or 2-MAA (98% pure, Aldrich Chemical, Milwaukee, WI lot S45804--438, pH adjusted to 6.2 with 10 M NaOH) were added to designated cultures.

Limb Morphology
---------------

Forelimbs were cultured for 6 days at 37°C, with a one-time change of medium and oxygenation on day 3 to replenish the nutrient supply, without further addition of either EGME or 2-MAA. Forelimbs were then fixed overnight in Bouin\'s fixative (Harleco, Gibbstown, NJ), stained overnight with 0.1% toluidine blue (Fisher Scientific, Montreal, QC, Canada) in 70% ethanol, dehydrated using an ethanol gradient, cleared, and stored in cedarwood oil (Fisher Scientific). Limbs were observed using a dissecting microscope and the morphology and differentiation of each limb were assessed using the limb morphogenetic differentiation scoring system (Neubert and Barrach, [@b21]). Briefly, this system attributes a score to the radius, ulna, carpalia, and each one of the five digits according to the differentiation status of the limb. Six to eight independent replicates (n = 6--8 bottles/group; 7--10 limbs per bottle) were completed.

Western Blotting
----------------

Forelimbs were cultured at 37°C for 1, 3, 6, or 24 hr. Forelimbs were then placed in liquid N~2~ and stored at −80°C. Limbs were later homogenized by sonication in lysis buffer containing protease inhibitors (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris pH 7.5, 40 μg/ml bestatin, 0.2M phenylmethylsulfonyl fluoride, 10 μg/ml leupeptin, and 6 μg/ml aprotinin). Total protein was extracted and content quantified using spectrophotometric Bio-Rad Protein Assays (Bio-Rad Laboratories, Mississauga, ON, Canada). Proteins (15--30 μg per sample) were separated by SDS-PAGE acrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes (BioSciences, Baie d'Urfé, QC, Canada). Precision standards (Bio-Rad Laboratories) were used as molecular weight markers. Membranes were blocked in 5% nonfat dried milk in TBS-T (137 mM NaCl, 20 mM Tris \[pH 7.4\], 0.05% Tween 20) at room temperature for 1 hr, probed overnight at 4°C with primary antibodies, washed in TBS-T, and incubated with the secondary antibody for 1 to 2 hr at room temperature. Immunoblotting was done using a polyclonal antibody against acetyl-histone H4 (Lys 12; H4K12ac, EMD Millipore, Billerica, MA, 04--119, 1:5000), acetyl-histone H3 (Lys 9; H3K9ac, EMD Millipore, 9649, 1:5000), acetyl-p53 (Lys 379; P53K379ac, Cell Signaling, Pickering, ON, 2570, 1:250), p53 (p53 \[FL-393\]; Santa Cruz Biotechnology, Santa Cruz, CA, SC-6243, 1:150), cleaved caspase-3 (Asp 175; Cell Signaling, 9661, 1:500), or beta-actin (Santa Cruz Biotechnology, SC-1616, 1:10,000). The secondary antibodies, donkey anti-rabbit antibody (GE Healthcare Limited, Baie d'Urfé, QC, Canada, NA-934, 1:5000) and anti-goat antibody (Santa Cruz Biotechnology, SC-2056, 1:10,000) conjugated to horseradish peroxidase (HRP), were used to detect specific antibody interactions. Western blots were visualized with the Enhanced Chemiluminescence Plus Kit (GE Healthcare Limited) and quantified by densitometry with the Chemi-Imager 4000 imaging system (Alpha Innotech, San Leandro, CA) and AlphaEase 3.3b software. Each sample consisted of an average of six to eight forelimbs; three to six separate Western blotting experiments were done for each antibody.

Real-Time qRT-PCR
-----------------

Total RNA from homogenized limbs (four to five limbs per group, *n* = 6) was extracted using an RNeasy Microkit or RNeasy Minikit (Qiagen, Mississauga, ON, Canada). The RNA concentration and purity of each sample were assessed by spectrophotometry using a NanoDrop1000 spectrophotometer (Fisher Scientific). The samples were diluted to a working concentration of 10 ng/μl and transcripts were quantified using Quantitect One-Step SYBR Green RT-PCR (Qiagen). Primers for *p21* (QT00137053) and *18S* rRNA (QT01036875) were purchased from Qiagen. The reactions were done in a final volume of 20 μl that was composed of 10 μl SYBR Green Master Mix, 2 μl of the primer, 0.2 μl Quantitect Reverse Transcriptase mix, 6.8 μl RNase-DNase-free water, and 1 μl sample. RT-PCR was done under the following conditions: 30 min at 50°C followed by 40 cycles of 95°C for 10 min, 95°C for 15 sec, 50°C for 1 min, and 60°C for 1 min. Serial dilutions of nontreated forelimb RNA samples were used to create a standard curve. Each reaction was done in triplicate, averaged, and normalized to the amount of 18S rRNA transcripts.

Statistical Analyses
--------------------

All morphology and protein quantification datasets were analyzed statistically using the Mann--Whitney U test and Bonferroni multiple-comparison correction with Systat 10.2 (Systat Software, Point Richmond, CA). The minimum level of significance was *p* \<0 .05. Data are expressed as means ± SEM.

RESULTS
=======

The Effects of EGME and 2-MAA on Limb Morphology
------------------------------------------------

The effects of EGME and 2-MAA on the morphology of embryonic forelimbs cultured in vitro are shown in Figure[1](#fig01){ref-type="fig"}. In both groups, the control limbs appeared normal, with properly developed radius, ulna, carpals, metacarpals, and phalanges. Treatment of limbs with increasing concentrations of EGME resulted in limb reduction at the highest concentration (30 mM) after 6 days in culture (Fig.[1](#fig01){ref-type="fig"}A). In comparison, the limbs treated with increasing concentrations of 2-MAA showed a concentration-dependent response starting at the lowest concentration (3 mM), with the most dramatic effects observed at the highest concentration (30 mM, Fig.[1](#fig01){ref-type="fig"}B). The defects observed in the limbs included a size reduction of the ulna and radius, poorly differentiated carpals, shortened metacarpals, fused digits, and missing digits. In EGME-treated limbs, the limb score was only significantly affected at the highest concentration (14% at 30 mM, Fig.[1](#fig01){ref-type="fig"}C), whereas in 2-MAA treated limbs there was a significant concentration-dependent decrease in limb score (12% at 3 mM; 40% at 10 mM; 64% at 30 mM; Fig.[1](#fig01){ref-type="fig"}D). These results reveal that in vitro exposure to 2-MAA, the proximate metabolite of EGME, had a dramatic impact on limb development.

![Embryonic day 12 forelimbs were cultured for 3 days in the presence of increasing concentrations of either EGME or 2-MAA (0, 3, 10, or 30 mM); on day 3 the culture medium was changed without further addition of EGME or 2-MAA and the bottles were oxygenated. Limbs remained in culture for three more days. They were stained with 0.1% toluidine blue (A and B) to visualize cartilage formation and scored according to their morphology (C and D). *n* = 6--8. \**p* \< 0.05, \*\*\**p* \< 0.005.](bdrb0101-0254-f1){#fig01}

Effects of EGME and 2-MAA on H3K9Ac and H4K12Ac
-----------------------------------------------

The effects of EGME and 2-MAA exposure on two specific histone acetylation sites, histone 3 lysine 9 (H3K9Ac) and histone 4 lysine 12 (H4K12Ac), were assessed as marks for effects on global HDAC activity and acetylation programming. The exposure of limbs to EGME did not alter the expression of either H3K9Ac or H4K12Ac at any concentration or time point (Fig.[2](#fig02){ref-type="fig"}A, C). However, exposure of limbs to 2-MAA resulted in a significant increase in H3K9Ac at 1 hr (3, 10, and 30 mM), 3 hr (3, 10, and 30 mM), 6 hr (30 mM), and 24 hr (3, 10, and 30 mM; Fig.[2](#fig02){ref-type="fig"}B). 2-MAA-exposed limbs also demonstrated a significant increase in H4K12Ac at 1 hr (3, 10, and 30 mM), 3 hr (3, 10, and 30 mM), 6 hr (10 and 30 mM), and 24 hr (3, 10, and 30 mM; Fig.[2](#fig02){ref-type="fig"}D).

![Western blot analysis of the effects on histone 3 lysine 9 acetylation (H3K9Ac, A and B) and on histone 4 lysine 12 acetylation (H4K12Ac, C and D) following a 3-hr exposure to EGME or 2-MAA. H3K9Ac and H4K12Ac were normalized to β-actin and quantified by densitometry in protein extracts from limbs cultured for 1, 3, 6, or 24 hr in the absence or presence of EGME or 2-MAA. Differences were analyzed by Mann--Whitney U test, followed by Bonferroni correction. *N* = 5; \**p* \< 0.05.](bdrb0101-0254-f2){#fig02}

Effects of EGME and 2-MAA on the Acetylation of p53K379Ac
---------------------------------------------------------

Neither EGME nor 2-MAA altered p53 protein levels compared to controls at any concentration or time point (Fig.[3](#fig03){ref-type="fig"}A, B). To determine the effects of EGME and 2-MAA on p53 acetylation, we used the commercially available antibody that detects murine p53 acetylated at lysine 379 (p53K379, equivalent to lysine 382 in human p53; Feng et al., [@b6]). EGME exposure did not affect the expression of p53K379Ac in limbs at any concentration or time point examined (Fig.[3](#fig03){ref-type="fig"}C). However, limbs exposed to 2-MAA showed a significant increase in the expression level of p53K379Ac at 3, 6, and 24 hr (10 and 30 mM, Fig.[3](#fig03){ref-type="fig"}D, E). Thus, 2-MAA exposure induced a significant increase in p53 acetylation in the absence of an overall effect on p53 protein concentrations.

![Western blot analysis of the effects of a 3-hr exposure to EGME or 2-MAA on total p53 (A and B) and on acetylated p53 at lysine 379 (p53K379Ac; C, D, and E). No p53K379Ac was detected in control or EGME-exposed limbs. p53K379Ac in limbs cultured for 1, 3, 6, or 24 hr in the presence of 2-MAA was normalized to β-actin and quantified by densitometry in protein extracts from (E). Differences were analyzed by Mann--Whitney U test, followed by Bonferroni correction, *N* = 5; \**p* \< 0.05.](bdrb0101-0254-f3){#fig03}

Effects of EGME and 2-MAA on p21 Steady-State Transcript Concentrations
-----------------------------------------------------------------------

Since acetylation of p53 at K379 has been demonstrated to be required for p53 binding at the *p21* promoter region (Zhao et al., [@b41]), we determined if *p21* expression levels were correlated with acetylated p53K379Ac. No changes in *p21* expression were observed at 3 hr in EGME treated samples (Fig.[4](#fig04){ref-type="fig"}A). In contrast, 2-MAA exposure resulted in the upregulation of *p21* mRNA expression at 3 hr (10 and 30 mM, Fig.[4](#fig04){ref-type="fig"}B). Therefore, there was a direct correlation between p53K379 acetylation and induction of *p21* expression.

![*P21* gene expression following EGME (A) or 2-MAA (B) exposure. Limbs were cultured with either chemical for 3 hr. *p21* mRNA was quantified by qRT-PCR, normalized to 18S rRNA, and expressed as a percentage of control. Differences were analyzed by Mann--Whitney U test, followed by Bonferroni correction, with *N* = 6; \**p* \< 0.05.](bdrb0101-0254-f4){#fig04}

Effects of EGME and 2-MAA on Caspase-3 Cleavage
-----------------------------------------------

Since p53 acetylation at K379 has been linked to the regulation of apoptosis (Zhao et al., [@b41]), we examined the effects of EGME and 2-MAA on protein levels of cleaved caspase-3, a marker of apoptosis. EGME exposure did not alter the amount of cleaved caspase-3 protein detected at any time point (Fig.[5](#fig05){ref-type="fig"}A). However, limbs exposed to 2-MAA showed a significant increase in the amounts of cleaved caspase-3 at 3, 6, and 24 hr (10 and 30 mM, Fig.[5](#fig05){ref-type="fig"}B). Thus, there was a direct correlation between p53K379Ac and cleaved caspase-3.

![Western blot analysis of the effects of exposure to EGME (A) and 2-MAA (B) on cleaved caspase-3 (C.3), a marker of apoptosis. C.3 was normalized to β-actin and quantified by densitometry in protein extracts from limbs cultured for 1, 3, 6, or 24 hr in the absence of presence of EGME or 2-MAA. Differences were analyzed by Mann--Whitney U test, followed by Bonferroni correction. *N* = 5; \**p* \< 0.05.](bdrb0101-0254-f5){#fig05}

DISCUSSION
==========

Although EGME and its primary metabolite, 2-MAA, are established teratogens, their mechanisms of action are still poorly understood. In this study, we demonstrated that exposure to 2-MAA caused a concentration-dependent increase in limb malformations in an in vitro limb bud culture system, whereas EGME exposure had only minimal effects at the highest concentration examined. Furthermore, this study provides the first evidence that the 2-MAA-induced limb malformations are strongly correlated with a deregulation of acetylation programming, suggesting that HDAC inhibition is the predominant mechanism of action.

A strong correlation between acetylated p53 K379 (equivalent to lysine 382 in human p53; Feng et al., [@b6]) and an increase in *p21* expression and in cleaved caspase-3 levels was observed after exposure to 2-MAA. Zhao et al. ([@b41]) demonstrated in A549 cells that HDACi depsipeptide induced acetylation of p53 at K373/382 sites but not at K320. Acetylation at K373/K382 was necessary for p53 binding at the *p21* promoter, thus promoting the induction of *p21* expression. Furthermore, Oh et al. ([@b22]) demonstrated that HDACi CG200745-induced cell death was resistant in a cell line in which p53 was mutated at K382. Therefore, the acetylation at p53 K379 plays an integral role in both cell cycle arrest and apoptosis.

EGME testicular toxicity in vivo was observed after dosing rats with 500 mg/kg for 2 days (Foster et al., [@b7]). These authors reported that up to 50 mM EGME had no effect on aggregates of Sertoli and germ cells in culture, whereas in vitro exposure to 5 mM 2-MAA affected pachytene spermatocytes (Foster et al., [@b7]). Yan et al. ([@b38]) demonstrated that 2-MAA-induced apoptosis in spermatocytes was correlated with the increased expression of the proapoptotic factors BAX and BAK. In another study, 2-MAA exposure resulted in an increase in the death of rat germ cells that was correlated with cytochrome C release and the activation of caspases 9 and 3 (Rao and Shaha, [@b24]). Here, we report that 2-MAA exposure increased cleaved-caspase-3 in developing limbs. In addition, 2-MAA exposure increased *p21* expression, an important marker for cell cycle arrest. Therefore, the combined effects of cell cycle arrest and increased apoptosis in the developing limb may lead to the limb malformations observed.

Exposure to 3-mM 2-MAA did not affect the acetylation of p53 at K379. At this concentration 2-MAA may not inhibit the HDACs that deacetylate p53, HDAC1, and SIRT1 (Brook and Gu, [@b2]). There was a strong correlation between the effects of 2-MAA on p53 (K379) acetylation and downstream activation of markers of cell cycle arrest and apoptosis. Overall, this study demonstrates that 2-MAA-induced disruption of limb development in vitro

is associated with a dysregulation of acetylation as early as 3 hr after exposure. Therefore, we propose that modifications in acetylation programming underlie the teratogenicity of 2-MAA.
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